AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced the appointment of Edward Jordan as senior vice president of sales and marketing. Mr. Jordan brings to AMAG more than 20 years of experience in U.S. and international pharmaceutical sales and marketing operations. Prior to joining AMAG, Mr. Jordan served as head of sales, marketing, and operations of the women’s health division at Teva Pharmaceuticals. In this role he led sales, marketing, training, and sales analytics for their branded pharmaceuticals, over-the-counter products and a medical device. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened at $21.71 in last trading session, and closed at $21.58, trading in the range of $21.37 – $21.99. The stock showed a positive weekly performance of 3.25%.
Atossa Genetics Inc (NASDAQ:ATOS) average recommendation is overweight with average Target Price of $8.75. Atossa Genetics Inc (NASDAQ:ATOS) shares closed at $2.35 on last trade day, by gaining 2.85%. Stock 52 week range is $1.74 – $12.40. Company’s market capitalization is $42.27 billion.
Palatin Technologies, Inc. (NYSEMKT:PTN) average recommendation is buy with average Target Price of $4.00. Palatin Technologies, Inc. (NYSEMKT:PTN) stock decreased -0.87% and finished the last session at $1.14. The EPS of the stock remained -0.14. Company’s market capitalization is $44.68 billion.
IDEXX Laboratories, Inc. (NASDAQ:IDXX), announced that it will participate in the Raymond James 35th Annual Institutional Investors Conference. Brian McKeon, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation on the Company on Tuesday, March 4, 2014 at 11:35 a.m. ET, at the JW Marriott Grande Lakes, Orlando, Florida. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock opened at $125.71 in last trading session and closed at $125.54. The 52 week range of the stock is $81.57 – $126.83 and the day range was $125.08 – $126.36.